A multicentre, prospective phase 2 study of weekly schedule of carboplatin (C) plus paclitaxel (P) in first-line treatment of elderly patients (pts) with ovarian cancer (OC). The MITO (Multicentre Italian Trials in Ovarian cancer)-5 study

Vittorina Zagonel, Sandro Pignata, Rocco De Vivo et al.|Journal of Clinical Oncology|2006

Cited by 0